AI Biology
“We are Here” - AI and Drug Discovery by Jeremy Jenkins, Novartis’ Head of US Discovery Sciences
A field note from Dr. Jeremy Jenkins's BioIT World 2026 plenary on where AI and drug discovery actually stand today. Not the hyped version, not a future projection. The current state of AI implementation, from inside Novartis.